<DOC>
	<DOCNO>NCT00437749</DOCNO>
	<brief_summary>Multiple Drug Resistance phenomenon whereby cell become resistant variety drug different mechanism action . Drug resistance remain significant impediment successful cancer chemotherapy inhibitor develop currently clinical trial . CBT-1 natural product currently clinical trial inhibitor</brief_summary>
	<brief_title>A Study CBT-1 Paclitaxel With Carboplatin Patients With Advanced Inoperable Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Lung cancer high incidence prevalence among cancer world remain leading cause cancer-related death Western country . One-year survival patient best supportive care remain low . Non-small-cell lung cancer account almost 85 % lung cancer case . Approximately 70 % patient locally advance metastatic disease presentation candidate surgery .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>histological confirm diagnosis NSCLC advance inoperable NSCLC adequate renal function , serum creatinine &lt; 2.0 mg/dL 24 hour creatinine clearance &gt; 50mL/minute adequate liver function define SGOT &lt; 4 time upper limit normal ( ULN ) bilirubin &lt; 2.0 mg/dL calcium &lt; 11.0 mg/dL albumin &gt; 2.0g/dL adequate bone marrow reserve define granulocyte count &gt; 1,500/mm3 , hemoglobin &gt; 10.0 g/dL platelet &gt; 100,000/mm3 female childbearing potential , agree use one follow method birth control : oral contraceptive , barrier spermicide , intrauterine progesterone contraceptive system , levonorgestrel implant , medroxyprogesterone acetate contraceptive injection , complete abstinence sexual intercourse previously receive taxanes , platinum , vinca alkaloid , anthracyclines , epipodophyllotoxins CBT1 know suspected hypersensitivity platinum contain compound , taxanes , polyoxyethylated castor oil , mannitol significant central nervous system disease , include history seizure within last 3 month psychiatric history would impair ability give inform consent prevent compliance protocol requirement eligible curative surgery radiotherapy . must diagnosis and/or treatment past 5 year malignancy NSCLC basal cell carcinoma skin pregnant nursing history significant coronary artery disease , cardiac arrhythmia require treatment , history cardiac disease cardiac anomaly determine ECG judgment investigator would compromise patient 's ability tolerate therapy ongoing serious infection require parenteral antibiotic clinically significant bleed disorder solid organ allograft significant intercurrent disease bleed peptic ulcer disease participate experimental study within 2 month precede enrollment use medication could interact adversely CBT1 , paclitaxel , carboplatin . Medications include : aminoglycoside antibiotic , Prilosec , Losec , Zantac</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Non small cell lung cancer</keyword>
	<keyword>Advanced</keyword>
	<keyword>Inoperable</keyword>
	<keyword>taxanes</keyword>
	<keyword>carboplatin</keyword>
	<keyword>multi-drug resistance</keyword>
</DOC>